129 related articles for article (PubMed ID: 10206071)
41. Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.
Rubenstein M; Tsui P; Guinan P
Med Oncol; 2008; 25(2):182-6. PubMed ID: 17972023
[TBL] [Abstract][Full Text] [Related]
42. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco AR; Ciardiello F
Oncol Rep; 1999; 6(5):1105-9. PubMed ID: 10425310
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH
Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides.
Liu X; Pogo BG
Antisense Nucleic Acid Drug Dev; 1996; 6(1):9-16. PubMed ID: 8783791
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor expression in human colon and colon carcinomas: anti-sense epidermal growth factor receptor RNA down-regulates the proliferation of human colon cancer cells.
Rajagopal S; Huang S; Moskal TL; Lee BN; el-Naggar AK; Chakrabarty S
Int J Cancer; 1995 Sep; 62(6):661-7. PubMed ID: 7558411
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
48. Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation.
Tian XX; Lam PY; Chen J; Pang JC; To SS; Di-Tomaso E; Ng HK
Neuropathol Appl Neurobiol; 1998 Oct; 24(5):389-96. PubMed ID: 9821170
[TBL] [Abstract][Full Text] [Related]
49. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
[TBL] [Abstract][Full Text] [Related]
50. erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
Colomer R; Lupu R; Bacus SS; Gelmann EP
Br J Cancer; 1994 Nov; 70(5):819-25. PubMed ID: 7947086
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
52. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
53. Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell line.
Hamburger AW; Pinnamaneni GD
Br J Cancer; 1991 Jul; 64(1):64-8. PubMed ID: 1906727
[TBL] [Abstract][Full Text] [Related]
54. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
55. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
56. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
57. Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells.
Alama A; Meazza R; Barbieri F; Biassoni R; Mazzei M; Nicolin A
Exp Cell Res; 1993 Jun; 206(2):318-22. PubMed ID: 8500551
[TBL] [Abstract][Full Text] [Related]
58. Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.
Barton CM; Lemoine NR
Br J Cancer; 1995 Mar; 71(3):429-37. PubMed ID: 7880719
[TBL] [Abstract][Full Text] [Related]
59. A study on the relationship between antisense EGFR cDNA fragments and nuclear matrix proteins in glioblastoma cells.
Wang ZH; Yam GH; Tian XX; Ng HK; Chew-Cheng SB; Ding MX; Chew EC
Int J Mol Med; 1998 Oct; 2(4):417-21. PubMed ID: 9857227
[TBL] [Abstract][Full Text] [Related]
60. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
